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Introduction
Endoplasmic reticulum (ER)-resident proteins are pivotal in an array of cellular functions, including protein synthesis and folding, disulfide bond formation, glycosylation and enzymatic processing of substrates. A fraction of these proteins is attached to the ER membrane through one (single-spanning membrane proteins) or multiple (polytopic proteins) transmembrane regions, or through a specific region that does not transverse the membrane, but loosely attaches to it through hydrophobic interactions. An intact topology of membrane proteins, i.e. their orientation in relation to the membrane, is crucial for their function and depicts important aspects of their physiology. Regarding ER enzymes, the catalytic site as well as the co-factor binding site can face either the ER lumen or the cytosol, which dictates the source site of substrate and co-factor and, hence, the site of biochemical reactions. In addition, the topology of ER enzymes defines the subcellular site of posttranslational modifications and interactions with other proteins, which are crucial for their biological functions.
Several methods have been developed for the determination of the topology of ER membrane proteins. Among them, the proteinase K protection assay is a commonly used biochemical method, which includes isolation of microsomal membranes, followed by cleavage of exposed protein domains by the proteinase and immuno-detection of the remaining protein fragment (for examples, see Refs. [1] [2] [3] [4] [5] ). This method is multi-step and laborious, and its credibility relies vastly on the quality of the microsomal preparation (e.g. on the percentage of inside-out orientation of the microsomal vesicles), as well as on the purity and activity of proteinase K. Another method used for the determination of the topology of ER membrane proteins is the selective permeabilization of cell membranes with specific detergents, such as digitonin [6] [7] [8] [9] [10] and saponin [11, 12] or pore-forming agents, such as streptolysin-O [13] [14] [15] , followed by immunofluorescence staining. The most commonly used reagent is digitonin, which permeabilizes a lipid bilayer by binding to cholesterol molecules that are much more abundant in the plasma membrane than in the ER membrane. Since the cholesterol content can significantly vary depending on the cell type, state and passage number, the success of this method relies on the duration of the incubation with the detergent, as well as the concentration used. Non-optimal conditions can lead to complete permeabilization of cell membranes. In addition, since partial permeabilization of ER membranes can occur, statistical analysis of the percentage of cells positive with digitonin in comparison with a detergent that fully penetrates all cell membranes (such as Triton X-100) is mandatory. For this purpose, proteins known to face the ER lumen or the cytosol should be included in the experiments as positive/negative controls.
Additionally, fluorescence-based methods to determine membrane protein topology have been developed, such as the fluorescence protease protection assay, which is, however, also based on selective permeabilization of cell membranes with digitonin [16, 17] . The bimolecular fluorescence complementation assay is another method employed for topology determination [18] , involving fusion of the protein of interest with the non-fluorescent half of yellow-fluorescent protein (YFP), and targeting of the other non-fluorescent half to the ER. This method requires spatial proximity of the two halves of YFP, as well as optimal conformational orientation, which then allows the full-length YFP protein to be formed, conditions that are often not fulfilled.
In order to develop a straightforward and reliable method for the determination of the topology of ER membrane proteins, we took advantage of the recently engineered redox-sensitive green fluorescent protein (roGFP) [19] [20] [21] . In roGFP two amino acids (aa) of the wildtype GFP have been substituted by cysteine residues. Depending on whether these cysteine residues form an intramolecular disulfide bond or not, the emission peaks of roGFP after excitation at 405 nm and 488 nm change in their intensity. The ratio of fluorescence intensity at these two wavelengths can be used to calculate the percentage of the oxidized form of roGFP in real-time. The ratiometric nature of roGFP renders it independent of parameters such as absolute probe concentration. We reasoned that fusion of roGFP at the C-terminus of a protein and measurement of roGFP oxidation would reflect whether this part of the protein resides in an oxidizing environment (ER lumen) or a reducing environment (cytosol). To date, roGFP proteins with slight differences in their aa sequence and variants of those, exhibiting discrete fluorescence properties, have been developed (roGFP1-roGFP6) [19] [20] [21] . For our experiments, we constructed fusions with roGFP2, since this variant shows a moderate oxidation in the ER at steady state [22] . roGFP2 shows a major peak at 488 nm in the reduced form, while in the oxidized form the peak is higher at 405 nm. Grx1-roGFP2 and Orp1-roGFP2 fusions have been successfully used as reporters of glutathione redox potential [23, 24] and H 2 O 2 [25, 26] content, respectively. However, the use of roGFP2 has not been established for topology assessment.
Here, as proof of principle, we constructed fusion of roGFP2 with the two microsomal enzymes 11β-HSD1 and 11β-HSD2, which have been shown to face the luminal and cytosolic compartment, respectively [27] [28] [29] [30] . We then implemented this method to unravel the intracellular localization and membrane topology of enzymes belonging to the 17βhydroxysteroid dehydrogenase (17β-HSD) family [31, 32] . 17β-HSD enzymes catalyze the reduction/oxidation at the position 17 of the steroid backbone of androgens and estrogens, thus playing a key role in the control of the balance of active and inactive sex steroids. Many 17β-HSDs have been implicated in different forms of sex-specific cancer [33] [34] [35] [36] and 17β-HSD inhibitors have lately attracted considerable interest as therapeutic targets [32, [37] [38] [39] [40] . Several members of this family are multifunctional and are involved in other essential biochemical reactions, such as the elongation of very long chain fatty acids [41] , cholesterol synthesis [42] and peroxisomal β-oxidation of fatty acids [43] . Thus, the elucidation of the functions of these enzymes requires further research.
In this paper, by fusing roGFP2 with a protein of interest, we were able to develop a simple, non-invasive and reliable method to assess the topology of ER membrane proteins in living cells. This method could prove useful as a tool to resolve the topology of any ER membrane protein.
Materials and methods

Cell culture and transient transfection
HEK-293 cells were cultured at 37°C and 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM) containing 2 mM L-glutamine, 4.5 mg/ml glucose, and supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 10 mM HEPES buffer pH 7.4 and nonessential amino acid solution. All cell culture materials were purchased from Sigma-Aldrich (Buchs, Switzerland). The transfections were performed using the calcium phosphate precipitation method [44] . For the triggering of lipid-droplet formation, oleic acid at a final concentration of 150 μΜ was added on cells 16 h prior to immunostaining.
Molecular cloning and expression constructs
To generate roGFP2 fusion proteins with human 11β-HSD1 (SDR26C1), 11β-HSD2 (SDR9C3), 17β-HSD1 (SDR28C1), 17β-HSD2 (SDR9C2), 17β-HSD2 (aa 1-88), 17β-HSD6 (SDR9C6), 17β-HSD6 (aa 1-35), 17β-HSD7 (SDR37C1), 17β-HSD11 (SDR16C2), 17β-HSD11 (aa 1-42), 17β-HSD12 (SDR12C1), 17β-HSD12 (aa 1-56), and 17β-HSD13 (SDR16C3), 17β-HSD13 (aa 1-42) we first subcloned roGFP2 into the pcDNA3 vector (Life Technologies, Zug, Switzerland) between the endonuclease restriction sites EcoRV and XbaI. A linker sequence (TCAGGA GGA) was added upstream of the roGFP2 sequence. The coding sequences of the above genes were amplified from donor vectors by PCR and subcloned upstream of roGFP2. 11β-HSD1, 17β-HSD1, 17β-HSD2, 17β-HSD2 (aa 1-88), 17βHSD7 and 17β-HSD11 were subcloned between the KpnI/EcoRV restriction sites. 17β-HSD6, 17β-HSD6 (aa 1-35), 17β-HSD12, 17β-HSD12 (1-42), 17β-HSD13, 17β-HSD13 (aa 1-42) and 11β-HSD2 were subcloned between HindIII/EcoRV and 17β-HSD11 (aa 1-42) between BamHI/EcoRV restriction sites. This strategy allowed the expression of C-terminally roGFP2-tagged proteins with a three aa linker (SGG, single letter aa code) between the protein of interest and roGFP2.
All of the full length flag-tagged constructs used for selective permeabilization experiments were produced by PCR amplification of the coding sequence from donor vectors and subcloned into the pcDNA3 vector. These constructs are: 11β-HSD1-FLAG, 11β-HSD2-FLAG, 17β-HSD2-FLAG, 17β-HSD6-FLAG, 17β-HSD7-FLAG, 17β-HSD11-FLAG, 17β-HSD12-FLAG and 17β-HSD13-FLAG. The sequence encoding the FLAG peptide was added to the oligonucleotide primers downstream of the coding sequence of the corresponding gene, for the production of C-terminally tagged proteins. For the N-terminally tagged 17β-HSD7 (FLAG-17β-HSD7) the FLAG epitope was added upstream of the coding sequence. All constructs were verified by sequencing. Primer sequences are available upon request.
Selective permeabilization and indirect immunofluorescence experiments
HEK-293 cells were seeded on glass coverslips and were transiently transfected after 24 h. At 48 h post-transfection cells were washed twice with PBS, fixed with 4% paraformaldehyde solution for 15 min and washed three times with PBS. For selective permeabilization of cell membranes, cells were incubated with 14 μΜ digitonin for 3 min. Complete permeabilization of all cell membranes was achieved by incubation of cells with 0.3% Triton X-100 for 5 min. After washing, blocking solution containing 2% defatted milk was added for 30 min, followed by incubation with primary antibody for 1 h. The antibodies used were mouse monoclonal anti-FLAG® M2 and rabbit anti-FLAG antibody (both from Sigma-Aldrich), mouse anti-PDI (Abcam, Cambridge, UK), rabbit anti-GFP [24] and rabbit monoclonal anti-17β-HSD1 (Ab51045, Abcam, Cambridge, UK). Cells were then washed four times and incubated for 30 min with Alexa Fluor® 488 goat anti-mouse IgG or Alexa Fluor® 555 goat anti-rabbit. Where needed, Hoechst-33342 was included in the secondary antibody solution (Molecular Probes®, Eugene, OR). After four washes with PBS, the cells were mounted in Mowiol 4-88 and the slides were left to settle for several hours at room temperature. Stainings were analyzed on an Olympus Fluoview 1000 laser scanning confocal microscope (Olympus, Center Valley, PA).
For the selective permeabilization experiments depicted in Table 1 , in order to determine the number of cells positive for antibody staining with Triton X-100 and digitonin, around 1000 cells were counted per sample in three independent experiments. With the calcium phosphate transfection method employed in our lab, we have observed a transfection efficiency of about 25%, analyzed 48 h after transfection, when using a vector for GFP expression. This has been calculated from the total number of cells counted in a bright field setting in comparison with the cells expressing GFP. After fixation of cells and permeabilization with 0.3% Triton X-100 for 5 min, the total number of cells was determined by Hoechst-33342 nuclear staining. The percentage of cells yielding a positive GFP signal after staining with a GFP-specific antibody and the number of cells expressing GFP, determined as described before, was almost identical. After having established that for GFP-transfected cells, we concluded that the number of transfected cells and the number of antibody-stained positive cells after Triton X-100 permeabilization is essentially the same. The only exception was FLAG-17β-HSD7 that showed lower expression levels, and the positive control with Triton X-100 yielded 15% stained cells.
Live cell microscopy and image analysis
Cells were transfected with the roGFP2-fusion expression plasmids on glass bottom dishes (Ibidi GmbH, Martinsried, Germany). After 48 h, cells were washed twice with HEPES buffer pH 7.4, containing 5.5 mM glucose, the dishes were transferred to an Olympus Fluoview 1000 laser scanning confocal microscope and visualized using a 60 × oil immersion objective (NA 1.40). The microscope was equipped with a 405 nm laser diode and a 488 nm argon laser. The pictures were taken with 512 × 512 pixels and the emission window was 505-605 nm. Pictures were taken at the steady state, 1 min after addition of 5 mM diamide and 5 min after addition of 20 mM dithiothreitol (DTT). The indicated concentrations were used on the basis of previous publications [19, 23, 24, 26] . For every transfected cell in the visual field one region of interest (ROI) was chosen. The background signal at the two different wavelengths was selected as a separate ROI outside the regions containing cells. The intensity of this signal was subtracted from the intensity value acquired for each ROI. The 405/488 nm ratios were then determined from the average signal intensities in background subtracted ROI.
The degree of sensor oxidation (OxD) for the roGFP2 fusion proteins was determined using the following equation [24] :
where R, R red and R ox represent the 405/488 nm fluorescence ratios at steady state, upon complete reduction or complete oxidation, respectively, and I min and I max represent the fluorescence intensities of fully oxidized and fully reduced roGFP2 measured upon excitation at 488 nm. The OxD value was calculated separately for every cell, and the values shown in the graphs represent the average from all cells measured per experiment, in three independent experiments.
In silico analysis
For the in silico analysis of the structure of different 17β-HSDs we implemented the Kyte and Doolittle hydropathy score [45] , using the online tool: http://gcat.davidson.edu/DGPB/kd/kyte-doolittle.htm. For the analysis of ΔG, z-coordinate and statistical analysis prediction we used the TOPCONS site (http://topcons.cbr.su.se/) [46] .
Results
Determination of 11β-HSD1 and 11β-HSD2 topology using roGFP2 fusion proteins
To investigate whether the degree of roGFP2 oxidation can be used to assess the topology of ER membrane proteins, we took advantage of two ER membrane enzymes whose topology has already been resolved, 11β-HSD1 and 11β-HSD2 [27, 28, 30] . The C-terminus of 11β-HSD1 faces the luminal side of the ER, whereas the C-terminus of 11β-HSD2 resides in the cytosol. We expressed fusion proteins of full-length 11β-HSD1 and 11β-HSD2 with roGFP2 attached to the C-terminus in HEK-293 cells, followed by live imaging at steady state, after complete oxidation of roGFP2 with diamide and complete reduction with DTT. The ratio of fluorescence intensity emission after excitation at 405 nm and 488 nm was measured and the percentage of roGFP2 oxidation was calculated. Representative images from the live cell measurements of the three different conditions are shown in Fig. 1 . The ratio of fluorescence intensity at 405 nm and 488 nm of 11β-HSD1-roGFP2 was typical for a luminal localization of the sensor, being relatively steady after addition of diamide (since the protein exists already in an oxidized state) and decreasing after reduction with DTT ( Fig. 1A) . In contrast, full length 11β-HSD2-roGFP2 exhibited a ratio typical of a cytosolic localization, increasing upon oxidation and decreasing to basal levels upon reduction ( Fig. 1B) . Calculation of the percentage of oxidation of roGFP2 was in agreement, with 11β-HSD1-roGFP2 exhibiting a much higher degree of oxidation compared to 11β-HSD2-roGFP2 (see also below, Fig. 5 ). Based on the above results, we concluded that roGFP2 fusions can be reliably used for the determination of protein localization and topology.
Subcellular localization of 17β-HSD enzymes
After validating the roGFP2 fusion system using 11β-HSD proteins, we applied it to determine the intracellular localization and topology of the 17β-HSD family of enzymes, which comprises 14 members. These enzymes not only have diverse functions, but also exhibit different subcellular localization. In the present study, we focused on resolving the membrane topology of the 17β-HSD enzymes that are bound to the ER membrane. 17β-HSD3 (SDR12C2) is an ER integral membrane protein, and its topology was resolved recently [3] . Based on previous work, 17β-HSD4 (SDR8C1) is located in peroxisomes, which is consistent with its role in β-oxidation of fatty acids [43, 47] . 17β-HSD8 (SDR30C1) and 17β-HSD10 (SDR5C1) have been shown to localize in Table 1 Quantification of selective permeabilization experiments for the full length 17β-HSDs. In each experiment 1000 cells were counted. 11β-HSD1 and 11β-HSD2 were used in every experiment as controls. The relative rate of digitonin positive cells represents the percentage of cells counted positive with digitonin divided by the percentage of cells positive with Triton X-100. Data represents mean ± S.D. from three independent experiments. mitochondria [48, 49] . 17β-HSD14 (SDR47C or DHRS10) was reported earlier to be a cytosolic protein and does not possess a putative transmembrane region [50] . 17β-HSD1 has been regarded to be a cytosolic protein based on its amino acid sequence. 17β-HSD1 is not predicted to possess transmembrane helices. Using a specific antibody against the protein we found that it does not exhibit a typical ER pattern and appears to be predominantly cytosolic. Based on our immunostaining, potential attachment to intracellular membranous organelles cannot be excluded (Fig. 2) . In addition, we tested the degree of oxidation of 17β-HSD1-roGFP2, which is consistent with cytosolic localization (see also below, Fig. 5 ). All the above enzymes were, therefore, not further considered in the present study. Expression of C-terminally FLAGtagged 17β-HSD2, 17β-HSD6, 17β-HSD7 and 17β-HSD12 resulted in a typical ER pattern, which was shown by localization of the FLAGtagged proteins at the same cellular compartment as the ER-resident protein PDI (Fig. 2 ). 17β-HSD11 and 17β-HSD13 are present in the ER, and were shown to also occupy organelles of lipid storage and mobilization, known as lipid droplets [51, 52] . To verify the intracellular localization of these two enzymes, we expressed in HEK-293 cells 17β-HSD11 and 17β-HSD13 bearing a FLAG epitope at the C-terminus. Staining with anti-FLAG antibody showed a typical ER pattern, with occasional presence of the proteins in lipid droplets. Importantly, addition of oleic acid, which promotes lipid droplet formation, resulted in relocalization of 17β-HSD11 and 17β-HSD13 into lipid droplets (Fig. 3 ).
3.3.
In silico analysis of the structural architecture of 17β-HSDs that reside at the ER To gain insight into the structure of the different enzymes, we first implemented the Kyte and Doolittle quantitative method for the determination of amino acid hydrophobicity for each protein [45] ( Fig. 4 ). High hydrophobicity scores in parts of the protein indicate potential membrane-spanning segments. In addition, we employed the ΔG prediction algorithm, which determines the apparent free energy difference for insertion of a sequence into the ER membrane by the Sec61 translocon [53] . This is combined with the depiction of the absolute value of the Z-coordinate, representing the predicted distance of a residue from the membrane center [54] . The TOPCONS algorithm combines five different algorithms of topology prediction into one consensus prediction [46] . Based on the models above, the 17β-HSD enzymes tested are predicted to contain one (or two in the case of 17β-HSD2) transmembrane helix very close to the N-terminus, with the exception of 17β-HSD7, which has a single putative transmembrane segment starting at around two thirds of its sequence. As described later, the presence of this transmembrane sequence and the transmembrane sequences close to the N-terminus for the remaining 17β-HSDs are in accordance with our results. Our experimental data additionally implies the presence of another transmembrane sequence close to the C-terminus for 17β-HSD6 and 17β-HSD12. The TOPCONS algorithm correctly predicts this second transmembrane sequence for 17β-HSD6, which, however, is not undoubtedly defined by the rest of the parameters tested, such as the ΔG. Also, TOPOCONS does not predict a second transmembrane segment for 17β-HSD12. However, the hidden Markov model prediction algorithm TMHMM supports the presence of this second transmembrane sequence, and so does the SCAMPI algorithm [55] , which is based on the position-specific contribution of individual amino acids in the free-energy of membrane insertion. Besides, the hydropathy analysis for 17β-HSD12 is not conclusive. Regarding the in and out (of the cytosol) orientation for the different sequences of the enzymes tested, we employed several prediction algorithms, including TOPCONS. However, we were not able to validate or disprove our results based on these analyses, since the predictions given by individual algorithms largely disagree. For this reason, the in-out prediction of the TOPCONS algorithm is not depicted.
Determination of the topology of 17β-HSDs at the ER membrane
First, we investigated the orientation of the C-terminus of the selected 17β-HSDs upon expression of full length roGFP2 fusions in HEK-293 cells and performing live cell imaging experiments 48 h after transfection. Based on the degree of oxidation of roGFP2, which varied between 8% and 20%, we concluded cytosolic orientation for the C-terminus of 17β-HSD2, 17β-HSD6, 17β-HSD7, 17β-HSD11, 17β-HSD12 and 17β-HSD13 ( Fig. 5 ). All the enzymes, with the exception of 17β-HSD7, are predicted to have a transmembrane region 3-6 amino acids after the N-terminus. As depicted in Fig. 4 , for some of the enzymes the presence of a second transmembrane region cannot be excluded, implying that the C-terminus and the active site of the enzymes could lie in different compartments. In order to investigate the compartment in which the co-factor binding site and active site of these enzymes reside (which appear after the first transmembrane region), we created truncated versions of the enzymes, in which roGFP2 is placed downstream the first transmembrane region thus replacing the co-factor binding site and active site. These proteins were named 17β-HSD2 (aa 1-88), 17β-HSD6 (aa 1-35), 17β-HSD11 (aa 1-42), 17β-HSD12 (aa 1-56) and 17β-HSD13 (aa 1-42). Live cell imaging experiments with these proteins revealed cytosolic localization for 17β-HSD2 (aa 1-88), 17β-HSD11 (aa 1-42) and 17β-HSD13 (aa 1-42). The percentage of oxidation of 17β-HSD11 (aa 1-42) was higher than usually observed for cytosolic proteins. The increased degree of oxidation of 17β-HSD11 (1-42) roGFP2 could be explained if a small fraction of this truncated protein was mislocalized. Another possible explanation could be that the specific microenvironment in which this truncated protein lies is slightly more oxidized in comparison to the rest of the cytosol. Luminal localization was observed for 17β-HSD6 (aa 1-35) and 17β-HSD12 (aa 1-56). The fact that these two enzymes exhibited cytosolic localization of the C-terminus, points towards the presence of a second transmembrane region, which would result in the active site and the C-terminus having different localizations.
Next, we sought to validate the results obtained with the roGFP2 fusions, with an independent method, i.e. selective permeabilization of cell membranes followed by immunofluorescence detection. For these experiments we used proteins tagged with the FLAG epitope, in order to investigate whether the presence of roGFP2 would affect the topology of the proteins with which it is fused. To confirm the results obtained from the full length roGFP2 fusions, we expressed full length C-terminally FLAG-tagged proteins in HEK-293 cells and selectively permeabilized cell membranes using digitonin or completely permeabilized with Triton X-100. In addition, 11β-HSD1 C-terminally tagged with FLAG (11β-HSD1-FLAG) was used as a luminal control and 11β-HSD2 C-terminally tagged with FLAG (11β-HSD2-FLAG) as a cytosolic control. After immunofluorescence staining against the FLAG epitope, the results were analyzed with fluorescence microscopy. Fig. 6 shows representative confocal images. The quantification of three independent experiments is given in Table 1. In the case of 17β-HSD2, 17β-HSD6, 17β-HSD7, 17β-HSD11, 17β-HSD12 and 17β-HSD13, the percentage of cells stained positive after treatment with digitonin or Triton X-100 were comparable, indicating a cytosolic localization of the C-terminus of these enzymes. The existence of dual/multiple orientations is unlikely for these enzymes, since this would be expected to result in a significantly lower number of positive cells with digitonin in comparison to Triton X-100. Importantly, the above results are in accordance with the data obtained from the roGFP2 experiments.
To attempt to validate the results obtained with the truncated roGFP2 fusions, we created truncated FLAG-tagged versions of 17β-HSD6 and17β-HSD12, which showed rather low expression levels upon transfection. This made it impossible to draw reliable conclusions from selective permeabilization experiments using these proteins. To overcome this issue, we performed selective permeabilization experiments utilizing the truncated roGFP2 proteins and this time assessing the accessibility of the anti-GFP antibody. In these experiments we could directly conclude on the number of transfected cells based on the presence of fluorescence emitted by roGFP2. Parallel analysis showed that 100% of transfected cells are stained with the anti-GFP antibody after Triton X-100 permeabilization. Therefore, for the quantification of cells stained with the anti-GFP antibody after digitonin permeabilization, we calculated the percentage of transfected cells (showing fluorescence because of roGFP2) that were also stained with the anti-GFP antibody ( Table 2 ). Our results revealed cytosolic localization for 17β-HSD2 (aa 1-88), 17β-HSD11 (aa 1-42) and 17β-HSD13 (aa 1-42) and luminal localization for 17β-HSD6 (aa 1-35) and 17β-HSD12 (aa 1-56). These results agree with those from the live imaging experiments using the truncated roGFP2 fusions.
As mentioned above, 17β-HSD7 is not predicted to contain an Nterminal transmembrane region, while a putative transmembrane helix seems to exist downstream of the active site. Therefore, for 17β-HSD7 it was not possible to directly determine the compartmental localization of the active site by creating a truncated form of the protein.
17β-HSD7 tagged with roGFP2 at the C-terminus exhibited a cytosolic orientation (Fig. 5) , which was supported by selective permeabilization experiments of 17β-HSD7-FLAG ( Fig. 6 and Table 1 ). In order to investigate the topology of the active site of the enzyme, we added a FLAG epitope tag at the N-terminus of 17β-HSD7. The expression of this construct was lower in comparison with the other constructs, possibly due to inefficient synthesis and/or insertion into the ER membrane or partial degradation of the N-terminally tagged protein. Although the rate of digitonin positive cells is higher than in other cases of luminal proteins, experiments with selective permeabilization are suggestive of luminal localization of the FLAG epitope ( Fig. 6 and Table 1 ). Since addition of epitope tags at the N-terminus of a protein could affect localization, due to the potential presence of signal peptides and other N-terminal determinants, we sought to confirm that in the FLAG-17β-HSD7 the Cterminus was cytosolic, as found in the previous experiments. For this purpose, we created the same construct containing at the C-terminus the roGFP2 sequence (FLAG-17β-HSD7-roGFP2). The degree of oxidation of roGFP2 in this protein was suggestive of a cytosolic localization of the sensor (not shown), which supports that the N-terminal FLAG epitope did not affect the orientation of the C-terminus. The above results suggest that the active site of 17β-HSD7 protrudes into the ER lumen, while its C-terminus is facing the cytosol.
Discussion
Elucidation of the exact topology of membrane proteins is necessary for understanding important aspects of their biological functions. The methods used so far to determine membrane protein topology are based on arduous biochemical procedures, such as selectivepermeabilization of cellular membranes followed by immunodetection and proteinase K treatment, which involves post-lysis manipulation of cells. On the other hand, fluorescence-based methods such as the fluorescence protease protection assay [16, 17] and the protein complementation assay [18] are invasive or require co-expression of two proteins that bear two halves of YFP, and subsequent reconstitution of full length YFP. Recently, a new method for topology assessment was developed based on a glycosylatable GFP variant [56] , which can also be used to assess topology of ER membrane proteins in live cells [57] . Since this method relies on the N-glycosylation of GFP rendering it non- Student's t-test showed that the difference among proteins belonging to the same group is not significant. The difference between proteins of groups a and b is significantly different with p ≤ 0.01. fluorescence in the ER lumen, validation with Western blot of proper GFP glycosylation upon fusion with the protein of interest is essential. Although more time consuming than the approach presented in the current study, the use of glycosylatable GFP variants may be advantageous for special cases where a given protein has multiple orientations.
Here, we report a straightforward and rapid method for the analysis of the topology of ER membrane proteins, based on the fusion of roGFP2 with the protein of interest. The results show that the degree of oxidation of roGFP2 correlates with the redox status of the environment in which it resides (more reduced in the cytosol and more oxidized in the ER lumen). The degree of oxidation of roGFP2 alters its emission peaks after excitation at two different wavelengths. The fluorescence intensity at these two wavelengths at the steady state and after subsequent addition of an oxidizing and a reducing agent can then be used to calculate the oxidation status of roGFP2. The method described involves the generation of a single fusion protein and requires a confocal microscope equipped with two common laser lines, at 405 nm and 488 nm. The measurement is non-invasive, since it is performed in living cells. In addition, the duration of the live measurement is short (10 min), allowing the analysis of several different samples in one experimental setting. The fluorescence intensity measurement is provided automatically by the confocal microscope analytical software, and the calculation of the ratio and OxD value is rather simple. This allows for both efficient data acquisition and processing. It has been reported that certain roGFP variants exhibit a dim fluorescence signal, and also that the baseline measurements can vary due to light-induced oxidation, which results in slight differences of the steady-state ratio of fluorescence between individual experiments [58, 59] . Using roGFP2, we have not encountered problems of fluorescence intensity and since our experiments are performed in darkness, the steady-state fluorescent levels of the sensor do not show significant variations between experiments.
As proof of principle, we applied the roGFP2 fusion method and confirmed the topology of 11β-HSD1 and 11β-HSD2, two enzymes with known ER membrane topology [27] [28] [29] [30] that essentially catalyze the local availability of active glucocorticoids to corticosteroid receptors [60] . In a next step, we determined the topology of enzymes of the 17β-HSD family (results summarized in Fig. 7 ). This constitutes a functionally diverse group of enzymes, some shown to play a pivotal role in sex steroid metabolism (17β-HSD1, 2, 3, 4, 5, 6, 7, 12 and 14) . Due to their function in regulating androgen and estrogen metabolism, differences in the expression and/or function of these enzymes are linked with developmental disorders, sex-specific syndromes and various types of cancers [31] . For example, 17β-HSD2 is involved in the oxidation of the active estrogen estradiol to its inactive form estrone and has been implicated in the development of colon and breast cancer [61] [62] [63] [64] [65] [66] . Furthermore, 17β-HSD2 inhibitors are evaluated for the treatment of osteoporosis, a disease mainly affecting postmenopausal women. A previous study suggested that 17β-HSD2 is an ER luminal enzyme [67] . This was Fig. 6 . Determination of the membrane topology of full length 17β-HSD2, 17β-HSD6, 17β-HSD7, 17β-HSD11, 17β-HSD12 and 17β-HSD13 by selective permeabilization. HEK-293 cells were transfected with expression plasmids coding for the indicated constructs. All proteins bear the FLAG tag at the C-terminus, except for FLAG-17β-HSD7, which bears an N-terminal FLAG tag. At 48 h post-transfection cells were fixed, permeabilized with 14 μM digitonin or 0.3% Triton X-100 and stained with the anti-FLAG antibody M2, followed by incubation with Alexa Fluor®488 antibody and Hoechst-33342 dye. Fluorescence was analyzed using confocal laser-scanning microscope and representative images from one experiment are shown (FLAG: green, Hoechst-33342: magenta).
Table 2
Quantification of selective permeabilization experiments for the truncated 17β-HSD-roGFP2 fusions. In each experiment 500 cells expressing roGFP2 were counted and assessed for anti-GFP staining after digitonin treatment. Full length 11β-HSD1-roGFP and 11β-HSD2-roGFP were used in every experiment as controls. based on primary sequence predictions, since the protein contains an ER retention motif in the carboxyl terminus, which was presumed to direct this part in the ER. A second study also supported luminal orientation of 17β-HSD2 based on an experiment using confocal microscopy and showing co-staining of 17β-HSD2 with the ER-resident protein BiP [68] . However, the resolving power of the confocal microscope by no means allows determination of a protein topology in a biological membrane. Thus, solid experimental data for the topology of 17β-HSD2 has been so far lacking. Our live-imaging measurements using 17β-HSD2-roGFP2 and 17β-HSD2 (1-88)-roGFP2 combined with the selective permeabilization experiments clearly demonstrate that this enzyme possesses an N-terminal membrane anchor and that its catalytic moiety and C-terminus are facing the cytosol. In this case, the roGFP2 fusion method allowed re-evaluation of previous topology findings.
In addition, we showed that 17β-HSD11 and 17β-HSD13, integral ER membrane proteins that are also found in lipid droplets, are facing the cytosol. This result was expected, since to our knowledge there is no regenerating system existing in lipid droplets for NADPH, an essential cofactor for the enzymatic activity of both proteins. De novo formation of lipid droplets is believed to occur through budding from the outer membrane of the ER. The precise mechanism of lipid droplet formation, including the manner by which ER membrane proteins are redirected to the lipid monolayer of lipid droplets, is not fully elucidated [69, 70] . For such studies, knowledge of membrane protein topology could prove useful.
Our results further show that 17β-HSD6 has its active site in the ER lumen, while its very C-terminal part protrudes into the cytosol. This enzyme is believed to play a role in the synthesis of the potent androgen dihydrotestosterone in a pathway by-passing testosterone production (the so-called 'backdoor pathway') [71, 72] . Furthermore, 17β-HSD6 was found to be down-regulated in prostate cancer [73] . Thus, the structural and functional study of this enzyme, including the elucidation of its dependence on the luminal NAD + pool, could provide important insight into androgen metabolism and steroid changes occurring in prostate cancer.
Another interesting member of the 17β-HSD family is 17β-HSD7, which was shown to be highly expressed in breast cancer tissues [74] . It is able to convert estrone to estradiol [75, 76] and also possesses 3-ketosteroid reductase activity by catalyzing the conversion of zymosterone to zymosterol [42, 77] , the latter being an essential step in de novo cholesterol synthesis. Our results demonstrate that the C-terminus of 17β-HSD7 protrudes into the cytosol, whereas its Nterminus and the active site are in the ER lumen. 17β-HSD12 is another multi-functional enzyme able to convert estrone to estradiol [78] and also participating in the second step of long-chain fatty acid elondation, by reducing 3-ketoacyl-CoA to hydroxylacyl-CoA [41] . Its expression has been correlated with poor prognosis in breast and ovarian cancer, which is believed to be linked with its role in fatty acid synthesis rather than its ability to convert estrone to estradiol [79, 80] . Our data shows that the active site of 17β-HSD12 is facing the ER lumen. Western blot assays in two previous publications have identified two separate bands relating to the protein, which are postulated to represent its N-glycosylated and unglycosylated forms [81, 82] . The potential Nglycosylation site resides in the part of the protein that according to our data faces the ER. This is consistent with the fact that Nglycosylation takes place in the ER lumen. Previously published hydrophobicity index calculations also support the possibility of one transmembrane domain close to the beginning of the protein and one near the end [41] , although the in silico analysis as shown in Fig. 4 does not yield unambiguous predictions, thus, experimental validation is necessary. Better understanding the physiology and function of 17β-HSD7 and 17β-HSD12 could provide important insight into their role in the vital biological processes of cholesterol synthesis and very long-chain fatty acid elongation, as well as into their involvement in breast cancer.
Besides 17β-HSDs, the vast number of ER membrane proteins is responsible for an array of different functions, including calcium homeostasis, protein folding, post-translational modifications and essential metabolic reactions. The topology of these proteins is closely related with their function. A good example is the conversion of cholesterol to cholesterol esters. This reaction can be performed by two isoforms of acyl-CoA:cholesterol acyltransferase (ACAT), ACAT1 and ACAT2. The active site of ACAT1 faces the cytosol where cholesterol esters are stored in lipid droplets. On the other hand, ACAT2 faces the ER lumen, in which cholesterol esters are stored as apo-B-containing lipoprotein particles [83] . Thus, the differential topology of the two ACAT isoforms determines their functional specificity. Isoform-specific inhibitors of the ACAT enzymes are currently considered for treatment of atherosclerosis through a reduction in blood cholesterol levels. Appropriate access of such inhibitors to the respective compartment needs to be considered in drug development.
Conclusions
We developed a non-invasive and rapid method using the roGFP2 ratiometric sensor for determination of ER membrane protein topology Fig. 7 . Schematic representation of the topology of 17β-HSD enzymes. The co-factor binding site (Rossman fold) and active site of 17β-HSD2, 17β-HSD3, 17β-HSD11 and 17βHSD-13 is facing the cytosol, whereas that of 17β-HSD6, 17β-HSD7 and 17β-HSD12 protrudes into the ER lumen. 17β-HSD1 does not possess a transmembrane region and is cytosolic. The topology of 11β-HSD1 and 11β-HSD2 that has been resolved previously is also depicted. The asterisk indicates the two 17β-HSDs that are also present in the lipid droplets (17β-HSD11 and 17β-HSD13).
in living cells, the knowledge of which could be useful for a multitude of different studies. In our work, we generated an expression vector that tags the roGFP2 at the C-terminus of the proteins of interest. Despite the advantages of the method described here, we cannot exclude that in certain cases fusion with roGFP2 might alter the folding and/or topology of a protein. Based on our validation experiments using selective permeabilization, this was not the case for any of the proteins tested in this study. With the appropriate design, addition of roGFP2 is also possible at the N-terminus. However, this in some cases may disturb correct localization, by masking signal peptides and other determinants located near the N-terminus. Caution should be taken for proteins that contain specific retention/retrieval signals at the C-terminus, such as the KDEL, KKXX or SKL motifs, since addition of any C-terminal tag will most likely alter their subcellular distribution. The same holds true for tail-anchored protein targeting, where C-terminal tags can disrupt the cellular machinery involved in their proper integration in the ER membranes. Testing whether addition of roGFP2 affects subcellular localization of a protein of interest is necessary, since the roGFP2 method was developed for ER membrane protein topology rather than subcellular localization assessment. Truncated forms of membrane proteins can be tested, since fusion to roGPF2 did not change the subcellular localization of truncated compared to full-length proteins. Fusion to roGFP2 seems to stabilize truncated forms of proteins, potentially through rendering the resulting proteins longer. Truncated versions of the same proteins tagged with FLAG exhibited very poor expression levels. Furthermore, with this method the complete topology of polytopic proteins can be dissected by adding roGFP2 before and after each transmembrane region. An interesting option for future studies remains to test the applicability of roGFP2 fusions for resolving the topology of proteins residing in other cellular compartments.
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